| |
| |
|
| Insider
Information: |
Shenouda Maged |
| Relationship: |
|
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
197,403 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$141,922 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
197,403 |
|
|
| Total
Value |
$141,922 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
3
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-3.0
|
0.0
|
| Percentage
Gain/Loss : |
 -4.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Relmada Therapeutics, Inc. |
RLMD |
Chief Financial Officer |
2024-01-31 |
34,903 |
2015-12-14 |
0 |
Premium* |
|
|
Protea Biosciences Group Inc |
PRGB |
Director |
2015-12-18 |
100,000 |
2015-12-18 |
0 |
Premium* |
|
|
First Wave Biopharma Ord Shs |
FWBI |
|
2018-12-28 |
62,500 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RLMD |
Relmada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2024-01-31 |
4 |
B |
$4.06 |
$27,943 |
D/D |
6,875 |
34,903 |
2.74 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2024-01-30 |
4 |
B |
$3.89 |
$58,323 |
D/D |
15,000 |
28,028 |
2.74 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2024-01-29 |
4 |
B |
$3.65 |
$39,450 |
D/D |
10,800 |
13,028 |
2.74 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
CFO |
• – – |
2021-03-10 |
4 |
AS |
$35.11 |
$83,313 |
D/D |
(2,373) |
2,228 |
0 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
CFO |
• – – |
2021-03-09 |
4 |
AS |
$35.42 |
$267,693 |
D/D |
(7,527) |
4,601 |
0 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
CFO |
• – – |
2021-03-08 |
4 |
AS |
$35.00 |
$3,500 |
D/D |
(100) |
12,128 |
0 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
CFO |
• – – |
2021-03-08 |
4 |
OE |
$3.24 |
$32,400 |
D/D |
10,000 |
12,228 |
0 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
CFO |
• – – |
2021-02-24 |
4 |
OE |
$3.24 |
$9,720 |
D/D |
3,000 |
5,228 |
0 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
CFO |
• – – |
2021-02-24 |
4 |
AS |
$33.74 |
$102,529 |
D/D |
(3,000) |
2,228 |
0 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
CFO |
• – – |
2021-02-11 |
4 |
AS |
$35.39 |
$50,542 |
D/D |
(1,428) |
2,228 |
0 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
CFO |
• – – |
2021-02-11 |
4 |
OE |
$3.24 |
$4,627 |
D/D |
1,428 |
3,656 |
0 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
CFO |
• – – |
2021-02-10 |
4 |
AS |
$35.20 |
$84,825 |
D/D |
(2,410) |
2,228 |
0 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
CFO |
• – – |
2021-02-09 |
4 |
AS |
$35.24 |
$188,843 |
D/D |
(5,359) |
4,638 |
0 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
CFO |
• – – |
2021-02-08 |
4 |
AS |
$35.04 |
$126,242 |
D/D |
(3,603) |
9,997 |
0 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
CFO |
• – – |
2021-02-08 |
4 |
OE |
$3.24 |
$36,845 |
D/D |
11,372 |
13,600 |
0 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
CFO |
• – – |
2021-02-03 |
4 |
AS |
$35.00 |
$3,500 |
D/D |
(100) |
2,228 |
0 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
CFO |
• – – |
2021-02-02 |
4 |
AS |
$35.04 |
$108,634 |
D/D |
(3,100) |
2,328 |
0 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
CFO |
• – – |
2021-02-02 |
4 |
OE |
$3.24 |
$10,368 |
D/D |
3,200 |
5,428 |
0 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
CFO |
• – – |
2021-01-27 |
4 |
AS |
$31.59 |
$95,778 |
D/D |
(3,000) |
2,228 |
0 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
CFO |
• – – |
2021-01-27 |
4 |
OE |
$3.24 |
$9,720 |
D/D |
3,000 |
5,228 |
0 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
CFO |
• – – |
2021-01-26 |
4 |
AS |
$35.16 |
$21,342 |
D/D |
(607) |
2,228 |
0 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
CFO |
• – – |
2021-01-25 |
4 |
AS |
$35.27 |
$45,146 |
D/D |
(1,280) |
2,835 |
0 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
CFO |
• – – |
2021-01-22 |
4 |
OE |
$324.00 |
$1,296,000 |
D/D |
4,000 |
6,228 |
0 |
- |
|
| RLMD |
Relmada Therapeutics, Inc... |
CFO |
• – – |
2021-01-22 |
4 |
AS |
$35.41 |
$75,124 |
D/D |
(2,113) |
4,115 |
0 |
% |
|
| RLMD |
Relmada Therapeutics, Inc... |
Director |
– • – |
2019-10-21 |
4 |
B |
$23.00 |
$22,494 |
D/D |
978 |
2,228 |
2.39 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
